New treatment available for repeated occlusion of arteries
A new endovascular brachytherapy procedure using liquid beta-emitting rhenium-188 is safe and effective in preventing restenosis in people with long-segment femoropopliteal in-stent stenosis, according to research published in the August issue of the Journal of Endovascular Therapy.
(HealthDay)—A new endovascular brachytherapy (EVBT) procedure using liquid beta-emitting rhenium-188 (Re-188) is safe and effective in preventing restenosis in people with long-segment femoropopliteal in-stent stenosis (ISS), according to research published in the August issue of the Journal of Endovascular Therapy.
Martin Werner, M.D., of Park Hospital in Leipzig, Germany, and colleagues conducted a study of 90 consecutive patients with symptomatic ISS/occlusion of the femoropopliteal segment who underwent angioplasty followed by a new EVBT method that uses liquid beta-emitting Re-188.
The researchers found the primary patency to be 95.2 percent at six months (follow-up of 88 patients) and 79.8 percent at 12 months (follow-up of 82 patients). One case of early stent thrombosis and two cases of late acute thrombotic occlusions occurred. Nine patients experienced ISS and 10 patients experienced reocclusion of the treated segment. Overall clinical status improved for 67.0 and 62.2 percent at six and 12 months, respectively.
"In this study, the treatment of femoral ISS with beta radiation was safe and effective," the authors write. "Angioplasty in combination with EVBT resulted in a favorable primary patency rate of almost 80 percent and clinical improvement after 12 months. Most patients had non-focal patterns of ISS (diffuse, proliferative, or total occlusion) and would have been expected to respond poorly to angioplasty alone."
More information: Abstract
Full Text
Editorial
Copyright © 2012 HealthDay. All rights reserved.
-
Drug-releasing stent shows promise for improving outcomes in patients with coronary artery disease
Apr 22, 2008 |
not rated yet |
0
-
Comparison of anticoagulants for angioplasty show similar outcomes
Mar 30, 2008 |
not rated yet |
0
-
First in man SESAME stent trial demonstrates 100 percent acute success rate
Nov 16, 2010 |
not rated yet |
0
-
Results of the REMEDEE trial reported at TCT 2011
Nov 11, 2011 |
not rated yet |
0
-
Complications in patients undergoing percutaneous coronary intervention tend to occur within first 30 days
Mar 24, 2012 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why angle of projectile has 2 solutions?
58 minutes ago
-
How much negative charge do I accumulate by touching the earth?
2 hours ago
-
Indeterminism in Classical Physics
7 hours ago
-
Current in two wires
8 hours ago
-
understanding the dipole model for Rayleigh scattering
10 hours ago
-
question on coriolis effect with drag force
16 hours ago
- More from Physics Forums - Classical Physics
More news stories
Registry confirms TAVI efficacy and safety in Asian patients
Transcatheter aortic valve implantation (TAVI) is effective and safe in Asian patients, according to early experience based on first results from a multicentre Asian registry reported at EuroPCR 2013.
Cardiology
2 hours ago |
not rated yet |
0
Diagnostic coronary angiography: Functional flow reserve changes decisions in 25 percent of cases
Routinely measuring fractional flow reserve (FFR) using pressure wire assessment during coronary angiography for diagnosis of chest pain leads to significant changes in the management of one in four patients, according to ...
Cardiology
5 hours ago |
not rated yet |
0
Feasibility trial reports deployment of new device for TAVI in aortic insufficiency
A new investigational device - the Helio System (TF-FA) - being developed for use with the Sapien XT Transcatheter Heart Valve was successfully deployed in all four patients in a small, first-in-human feasibility study of ...
Cardiology
5 hours ago |
not rated yet |
0
Cardiac study used as source for new guidelines on treating people undergoing coronary artery bypass surgery
Cardiac research from the University of Alberta had serious impact as a source for the American College of Cardiology and the American Heart Association's new guidelines on how to treat patients undergoing coronary artery ...
Cardiology
6 hours ago |
not rated yet |
0
Dual-source cardiac CT IDs CAD in hard-to-image patients
(HealthDay)—In patients who have previously been considered difficult to image, dual-source cardiac (DSC) computed tomography (CT) can identify clinically significant coronary artery disease, according ...
Cardiology
20 hours ago |
not rated yet |
0
About one in four uninsured could be excluded from ACA
(HealthDay)—More than one in four of those eligible for new premium assistance tax credits under the Affordable Care Act (ACA) do not have a checking account and will not be able to receive premiums from ...
Comorbidities common with alopecia areata
(HealthDay)—Comorbid conditions often accompany alopecia areata, according to a study published online May 22 in JAMA Dermatology.
Pollen count apps for smartphones are nothing to sneeze at
Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.
Hormone levels may provide key to understanding psychological disorders in women
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
Engineered cytomegalovirus protects monkeys from HIV equivalent
(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...
Going live: Immune cell activation in multiple sclerosis
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
